A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder.
- DOI
- 10.1038/s41386-022-01295-4
- Published
- 2022 May
- Container
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41386-022-01295-4,
title = {A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder.},
author = {McDougle CJ and Thom RP and Ravichandran CT and Palumbo ML and Politte LC and Mullett JE and Keary CJ and Erickson CA and Stigler KA and Mathieu-Frasier L and Posey DJ},
year = {2022},
journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology},
doi = {10.1038/s41386-022-01295-4},
url = {https://doi.org/10.1038/s41386-022-01295-4}
}RIS
TY - JOUR TI - A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder. AU - McDougle CJ AU - Thom RP AU - Ravichandran CT AU - Palumbo ML AU - Politte LC AU - Mullett JE AU - Keary CJ AU - Erickson CA AU - Stigler KA AU - Mathieu-Frasier L AU - Posey DJ PY - 2022 JO - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology DO - 10.1038/s41386-022-01295-4 UR - https://doi.org/10.1038/s41386-022-01295-4 ER -
APA
CJ, M., RP, T., CT, R., ML, P., LC, P., JE, M., CJ, K., CA, E., KA, S., L, M., & DJ, P. (2022). A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. https://doi.org/10.1038/s41386-022-01295-4
Source records
- pubmed · retrieved 2026-09-26T23:36:52.152Z